Latest & greatest articles for cerebral palsy

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on cerebral palsy or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on cerebral palsy and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for cerebral palsy

161. The efficacy of botulinum toxin A in the treatment of spasticity in ambulant children with cerebral palsy: a structured review

The efficacy of botulinum toxin A in the treatment of spasticity in ambulant children with cerebral palsy: a structured review The efficacy of botulinum toxin A in the treatment of spasticity in ambulant children with cerebral palsy: a structured review The efficacy of botulinum toxin A in the treatment of spasticity in ambulant children with cerebral palsy: a structured review Mulligan H, Borkin H, Chaplin K, Croft N, Scherp A Authors' objectives To investigate the efficacy of Botulinum toxin (...) A (BtA) in the treatment of spasticity for the functional outcome of ambulation in children with cerebral palsy. Searching MEDLINE, EMBASE, AMED, EMB Reviews, CINAHL and PEDro were searched using the terms 'Botulinum toxin A' and 'cerebral palsy'. Limitations on the search included articles that were available in New Zealand and those that were written in English. Study selection Study designs of evaluations included in the review Randomised controlled trials (RCTs) or self-controlled experimental

2001 DARE.

162. Management of upper limb dysfunction in children with cerebral palsy: a systematic review

Management of upper limb dysfunction in children with cerebral palsy: a systematic review Management of upper limb dysfunction in children with cerebral palsy: a systematic review Management of upper limb dysfunction in children with cerebral palsy: a systematic review Boyd R N, Morris M E, Graham H K Authors' objectives To evaluate the efficacy of different treatments for the management of upper limb dysfunction in children with cerebral palsy (CP). Searching The following databases were (...) searched: MEDLINE from 1966 to December 2000; CINAHL from 1982 to December 2000; ClinPSYC from 1989 to December 2000; DARE (September 2000); PEDro; EBM Reviews: Best Evidence from 1991 to December 2000; the Cochrane Database of Systematic Reviews (Issue 4, 2000); and the Cochrane Controlled Trials Register (CENTRAL/CCTR). The exploded search terms used were 'cerebral palsy', 'upper limb', 'spasticity', 'physical therapy or physiotherapy', 'occupational therapy', 'neurodevelopmental therapy

2001 DARE.

163. Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review

Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review Boyd R N, Hays R M Authors' objectives To review systematically the current available evidence for botulinum toxin type (...) A (BTX-A) in cerebral palsy management, compared with other options for the lower limb and general body involvement in children. Searching The following sources were searched in December 2000: MEDLINE from 1966; CINAHL (via OVID) from 1982; ClinPSYC from 1989; DARE, PEDro; EBM Reviews: Best Evidence from 1991; the Cochrane Database of Systematic Reviews (Issue 4, 2000); and the Cochrane Controlled Trials Register (CENTRAL/CCTR). The exploded terms used were 'cerebral palsy', 'Botulinum toxin

2001 DARE.

164. Botulinum toxin type A in the management of equinus in children with cerebral palsy: an evidence-based economic evaluation

Botulinum toxin type A in the management of equinus in children with cerebral palsy: an evidence-based economic evaluation Botulinum toxin type A in the management of equinus in children with cerebral palsy: an evidence-based economic evaluation Botulinum toxin type A in the management of equinus in children with cerebral palsy: an evidence-based economic evaluation Houltram J, Noble I, Boyd R N, Corry I, Flett P, Graham H K Record Status This is a critical abstract of an economic evaluation (...) that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Two treatments for the conservative (non-surgical) management of equinus due to calf spasticity, in children with cerebral palsy, were examined. The treatments were intramuscular injection of botulinum toxin type A (BTX-A) and serial casting (SC). The dose

2001 NHS Economic Evaluation Database.

165. Conductive education – an educational program for children with cerebral palsy</a>

Conductive education – an educational program for children with cerebral palsy Conductive education – an educational program for children with cerebral palsy We use cookies on this website. By using this site, you agree that we may store and access cookies on your device. Swedish Agency for Health Technology Assessment and Assessment of Social Services Conductive education – an educational program for children with cerebral palsy Share: Reading time approx. 3 minutes This document (...) was published more than 2 years ago. The nature of the evidence may have changed. Findings by SBU Alert This is a translation of version 1, published on June 16, 2000. The latest version of this report is not available in English. Conductive education (CE) is an educational treatment program used mainly in children with motor disorders caused by Cerebral Palsy (CP). Conductive education is usually used as a complement to other treatment methods. The method was developed by Dr. András Petö in Budapest

2001 Swedish Council on Technology Assessement

166. [Cost-benefit of the pharmacologic treatment of cerebral palsy with spasticity in Mexico]

[Cost-benefit of the pharmacologic treatment of cerebral palsy with spasticity in Mexico] Coste-beneficio del tratamiento farmacologico de la paralisis cerebral con espasticidad en Mexico [Cost-benefit of the pharmacologic treatment of cerebral palsy with spasticity in Mexico] Coste-beneficio del tratamiento farmacologico de la paralisis cerebral con espasticidad en Mexico [Cost-benefit of the pharmacologic treatment of cerebral palsy with spasticity in Mexico] Arroyave Loaiza G, Jarillo Soto E (...) C, Garfias Garnica M G, Ribera Ibarra D B, Uribe Zamarripa J A Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The use of botulinum toxin A, a pharmacologic treatment for children suffering from cerebral palsy with spasticity

2000 NHS Economic Evaluation Database.

167. Conductive education for children with cerebral palsy

Conductive education for children with cerebral palsy Conductive education for children with cerebral palsy Conductive education for children with cerebral palsy Ludwig S, Leggett P, Harstall C Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Ludwig S, Leggett P, Harstall C. Conductive education for children with cerebral palsy. Edmonton (...) : Alberta Heritage Foundation for Medical Research (AHFMR). AHFMR HTA Report 22. 2000 Authors' objectives This report aims to assess the impact of conductive education (CE) on the overall learning and health status of children with cerebral palsy (CP). CE is an intervention which is most commonly used for children with CP, but it is also used in the treatment of children with spina bifida and other motor disorders. It is also used for adults with motor disorders. Authors' conclusions Because

2000 Health Technology Assessment (HTA) Database.

168. Dorsal rhizotomy and intrathecal baclofen for lower extremity spasticity associated with cerebral palsy

Dorsal rhizotomy and intrathecal baclofen for lower extremity spasticity associated with cerebral palsy Dorsal rhizotomy and intrathecal baclofen for lower extremity spasticity associated with cerebral palsy Dorsal rhizotomy and intrathecal baclofen for lower extremity spasticity associated with cerebral palsy Institute for Clinical Systems Improvement Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has (...) been made for the HTA database. Citation Institute for Clinical Systems Improvement. Dorsal rhizotomy and intrathecal baclofen for lower extremity spasticity associated with cerebral palsy. Bloomington MN: Institute for Clinical Systems Improvement (ICSI) 2000 Authors' objectives This review aims to assess the available evidence on the effectiveness of dorsal rhizotomy and intrathecal baclofen for lower extremity spasticity associated with cerebral palsy. Authors' conclusions Based on a review

2000 Health Technology Assessment (HTA) Database.

169. Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy

Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy Butler C, Campbell S Authors' objectives The authors appear to have studied the effects of intrathecal baclofen (ITB) on spastic and dystonic cerebral palsy (CP). Searching MEDLINE was searched ('from 1956 to March 2000'); the search (...) in this population should be provided to determine rates of adverse outcomes and to facilitate risk/benefit analysis. A standardised classification of CP and a valid and reliable measurement scale are needed to allow consistent diagnosis and measurement of dystonic CP. Bibliographic details Butler C, Campbell S. Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy. Developmental Medicine and Child Neurology 2000; 42(9): 634-645 PubMedID Indexing Status Subject indexing assigned

2000 DARE.

170. Conductive education for children with cerebral palsy

Conductive education for children with cerebral palsy Conductive education for children with cerebral palsy Conductive education for children with cerebral palsy Ludwig S, Leggett P, Harstall C Authors' objectives The authors' apparent objective was to systematically review the published scientific evidence regarding the impact of conductive education (CE) on the overall learning and health status of children with cerebral palsy. Searching The following databases were searched: MEDLINE from (...) ', 'education', 'strategy', 'therapy', 'therapeutic intervention', 'special education', 'early intervention', 'function training', 'teaching methods', 'client education', 'rehabilitation', 'educational methods', 'cerebral palsy', 'motor dysfunction', and 'motor neurone disease'. In addition, the websites of the National Institute of Conductive Education (Birmingham, UK), the Inter-American Conductive Education Association, Families of Alberta for CE (FACE), the Cerebral Palsy website, Peto Institute

2000 DARE.

171. Computerized gait analysis in the rehabilitation of children With cerebral palsy and spina bifida

Computerized gait analysis in the rehabilitation of children With cerebral palsy and spina bifida Computerized gait analysis in the rehabilitation of children with cerebral palsy and spina bifida Computerized gait analysis in the rehabilitation of children with cerebral palsy and spina bifida Tomie J-A, Hailey D Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made (...) for the HTA database. Citation Tomie J-A, Hailey D. Computerized gait analysis in the rehabilitation of children with cerebral palsy and spina bifida. Alberta Heritage Foundation for Medical Research (AHFMR) 1997: 38 Authors' objectives To assess the use of computerized gait analysis in the management of children with cerebral palsy or spina bifida, with specific reference to pre-treatment Decision making and post-treatment assessment. Authors' conclusions On the basis of information available

1997 Health Technology Assessment (HTA) Database.

172. Review of the effects of progressive resisted muscle strengthening in children with cerebral palsy: a clinical consensus exercise

Review of the effects of progressive resisted muscle strengthening in children with cerebral palsy: a clinical consensus exercise Review of the effects of progressive resisted muscle strengthening in children with cerebral palsy: a clinical consensus exercise Review of the effects of progressive resisted muscle strengthening in children with cerebral palsy: a clinical consensus exercise Darrah J, Fan J S, Chen L C, Nunweiler J, Watkins B Authors' objectives To determine the effects (...) of progressive resisted muscle strengthening for children with a diagnosis of cerebral palsy (CP). Searching MEDLINE, CINAHL, ERIC, PsycINFO and Sport Discus were searched from 1996 onwards, as well as bibliographies.Search terms used were included. Earlier studies were identified from bibliographies. Study selection Study designs of evaluations included in the review All designs were included. One study was a randomised controlled trial (RCT) and the other included studies were case series with no controls

1997 DARE.

173. Intrathecal baclofen for spasticity in cerebral palsy. (Abstract)

Intrathecal baclofen for spasticity in cerebral palsy. Seventeen patients with congenital spastic cerebral palsy and six patients with other forms of spasticity were injected intrathecally with doses of placebo or baclofen, 25 micrograms, 50 micrograms, or 100 micrograms, in a randomized, double-blind manner. Muscle tone in the upper and lower extremities was assessed by Ashworth scores both before the injections and every 2 hours afterward for 8 hours. Function of the upper extremities (...) in children with cerebral palsy, as it does in adults with spasticity of spinal origin.

1991 JAMA Controlled trial quality: uncertain

174. Cerebral palsy among children born during the Dublin randomised trial of intrapartum monitoring. (Abstract)

Cerebral palsy among children born during the Dublin randomised trial of intrapartum monitoring. In a randomised trial involving 13,079 liveborn children intrapartum care by electronic fetal heart rate monitoring, with scalp blood sampling when indicated, was associated with a 55% reduction in neonatal seizures. Reassessment, when aged 4, of the 9 children in the intensively monitored group and 21 in the control group who survived after neonatal seizures showed that 3 such children in each (...) group had cerebral palsy. A fourth child in the intensively monitored group with cerebral palsy had had transient abnormal neurological signs during the neonatal period. 8 other children in the intensively monitored group and 7 in the control group who had not had abnormal neurological signs in the neonatal period also had cerebral palsy. 16 (78%) of the total of 22 cases of cerebral palsy had not shown clinical signs suggestive of intrapartum asphyxia. Thus, compared with intermittent intrapartum

1989 Lancet Controlled trial quality: uncertain

175. The effects of physical therapy on cerebral palsy. A controlled trial in infants with spastic diplegia. (Abstract)

The effects of physical therapy on cerebral palsy. A controlled trial in infants with spastic diplegia. Legislatively mandated programs for early intervention on behalf of handicapped infants often stipulate the inclusion of physical therapy as a major component of treatment for cerebral palsy. To evaluate the effects of physical therapy, we randomly assigned 48 infants (12 to 19 months of age) with mild to severe spastic diplegia to receive either 12 months of physical therapy (Group A) or 6

1988 NEJM Controlled trial quality: uncertain